We’re proud to announce that Frontier Zdravlje has received regulatory approval in Serbia to launch Dermifin, a topical spray containing naftifine (10 mg/mL), for the treatment of topical fungal infections.

 

Dermifin strengthens our growing OTC portfolio and joins Vioplex, a well-recognized neomycin-bacitracin antibiotic spray, which is quickly becoming a household name in Serbia.

 

This milestone is a testament to the dedication, expertise, and collaboration of our cross-functional teams and broad coverage of the large topical anti-infectives category. 

 

Thank you to everyone who made this success possible!